Outspoken Oncology

Chadi makes his rounds at the Oncology Clinical Pathways Congress, catching guests and presenters such as Blase Polite, Alan Balch, and Lee Schwartzberg for some candid conversation and feedback.

Bobby Daly, MD, MBA, Memorial Sloan Kettering Cancer Center, breaks down prevalent touch points in oncology clinical pathways, including conflicts of interest on pathway development panels, potential for cost variation due to site of care, and interoperability challenges between vendor pathways and individual EMRs.

Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, debates with Chadi some of the ideas laid out in his book, "The Death of Cancer," most notably the utility of randomized controlled trials in regulatory approvals.

Mark A Lewis, MD, director of GI oncology, Intermountain Healthcare, spoke with Chadi to classify the AYA patient population, explain the disconnect of clinical trial accrual in this population, and pose social media as a critical avenue for overcoming this barrier.

Pat Basu, MD, MBA, president and CEO of Cancer Treatment Centers of America and former Senior Advisor to President Obama in the White House, shares with Chadi his unique experience of combining the clinical health care discipline with business and policy to help patients on a population level.

Sekar Kathiresan, MD, sits down with Chadi to discuss his unique career path from esteemed cardiologist and physician-geneticist at Massachusetts General Hospital to co-founder and CEO of Verve Therapeutics.

Opinions collide in this spirited debate about how physicians can and should enter conversations on political issues as Chadi and returning guest Saurabh Jha expound on a recent Lancet article focused on the Kashmir conflict.

Nathan Pennell, MD, PhD, and Chadi deliberate on some timely topics in non-small cell lung cancer treatment just before the World Lung Conference convenes, including screening, adjuvant therapy, metastatic disease, and ensuring patient adherence to oral therapies.

Rebecca Berger, MD, shares with Chadi the dilemma of oncology patient handoffs as well as the physician-to-hospitalist relationship.

Jeremy Warner, MD, MS, sits down with Chadi to discuss big data, explain how medical errors were part of the impetus toward EMR popularization, and project the future of EMRs and interoperability.

Matthew Katz, MD, provides the distinguishing factors between all forms of radiation therapy used in oncology today, including brachytherapy, SBRT, hypofractionated radiation therapy, and proton therapy, among others.

Narjust Duma, MD, thoracic oncologist at the University of Wisconsin, enlightens Chadi on gender bias in academic medicine, challenges facing women mentees, and her provocative research presentation at the recent ASCO annual meeting.

Jeremy Topin, MD, delves into a conversation with Chadi that focuses on improving communication in end-of-life care and the societal shift necessary to change the negative stigma surrounding such care.

Vinny Arora, MD, MAPP, award-winning mentor and professor, discusses with Chadi the attributes of a successful mentor-to-mentee relationship and issues regarding mentoring the future generations of physicians.

Chadi hosts a conversation with geriatric oncology experts William Dale, MD, PhD, and Supriya Mohile, MD, MS, to explore geriatric assessment, challenges in training oncology fellows, and the perpetual conundrum of oncology clinical trials and inclusion of geriatric patients.